Rabdomyolyse bij de combinatie statine + macrolide

Translated title of the contribution: Rhabdomyolysis by combined treatment with statin and macrolide antibiotic

S. R. Postma, J. I. Van Der Spoel, P. H M Egbers, E. J F Franssen, P. H J Van Der Voort*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Statins are frequently used as lipid-lowering drugs. Their pleiotropy also makes them beneficial for patients who develop sepsis. As a consequence, intensivists are inclined to continue statin therapy in patients with sepsis. We describe two intensive care patients who developed rhabdomyoiysis during combined treatment with simvastatin and erythromycin. Erythromycin, as an inhibitor of cytochrome P450, increases the risk of statin-related rhabdomyoiysis. The combination of macrolide antibiotics and statins should therefore be avoided in intensive care.

Original languageDutch
Pages (from-to)45-47
Number of pages3
JournalPharmaceutisch Weekblad
Volume142
Issue number11
Publication statusPublished - 16 Mar 2007

Cite this

Postma, S. R., Van Der Spoel, J. I., Egbers, P. H. M., Franssen, E. J. F., & Van Der Voort, P. H. J. (2007). Rabdomyolyse bij de combinatie statine + macrolide. Pharmaceutisch Weekblad, 142(11), 45-47.